We are pleased to announce the offering by RHBIB of up to 50,000,000 non-collateralised European-style cash settled call warrants over ordinary shares of SUNMED by way of market making.

The SUNMED-CO is to be listed on the Structured Warrants Board of Bursa Malaysia Securities Berhad.

The SUNMED-CO is constituted by the Deed Poll dated 8 October 2025. The SUNMED-CO is subject to the terms and conditions of the Base Prospectus dated 17 October 2025, the First Supplementary Base Prospectus dated 14 November 2025, the Second Supplementary Base Prospectus dated 22 January 2026 and the Third Supplementary Base Prospectus dated 18 March 2026.

The salient terms of the SUNMED-CO are set out in the attachment.  

This announcement is dated 17 April 2026.